Study
Authors
Year
Institution
Part One — Frisby Near Stereotest
A. History & Foundational Design
Frisby, J.P., Mein, J., Saye, A., Stanworth, A.
1975
University of Sheffield, UK
Introduced the first stereotest to use real, natural-depth random element targets requiring no dissociating glasses.
B. Validity & Monocular-Clue Studies
Cooper, J., Feldman, J.
1979
USA
Only 1 of 34 adult subjects could pass the test using monocular clues alone.
Rosner, J., Clift, G.D.
1984
USA
Correlation (r = 0.73, p<.001) between Frisby and TNO results.
Simons, K.
1981
Wills Eye Hospital, Philadelphia, PA, USA
Frisby reliably graded stereopsis in both preschool screening and clinical office settings; missed some cases that RDE/TNO caught.
Piro, M., Salmon, D., Ardouin, M.
1982
Rennes, France
“The Frisby test seemed to be the best test for children” when correctly presented.
Manny, R.E., Martinez, A.T., Fern, K.D.
1991
USA
No child with normal binocular vision could pass the Frisby test monocularly; children with constant strabismus couldn’t detect even large disparities; two anisometropic amblyopes tested within normal limits.
Lindstrom, A., Davis, H., Frisby, J.P.
2009
UK
Examines the relationship between measured stereoacuity and perceived binocular depth, co-authored by the test's own developers.
Saunders, K.J., Westall, C.A.
1996
UK / Canada
A structured training protocol improved reliable testability in very young children.
Saunders, K.J., Woodhouse, J.M., Westall, C.A.
1996
University of Wales College of Cardiff, UK
Extended reliable Frisby testing down to 7 months of age; over 60% testable by 12 months.
Fricke, T.R., Siderov, J.
1997
University of Melbourne / Victorian College of Optometry, Australia
Frisby stereoacuity is virtually unaffected by refractive blur, unlike the RDE stereotest — supporting its use where other RDS tests are compromised.
Fauveau, M., Rousseau, B., Crepy, P., et al.
2012
Hôpital d'Instruction des Armées, Clamart / Institut Mutualiste Montsouris, Paris, France
In 77 Air Crew applicants, Frisby Near averaged 15″ vs TNO's 60″, with no significant agreement between the two tests.
Piano, M.E.F., Tidbury, L.P., O'Connor, A.R.
2016
Strabismus, 24(4), 169-172
Independent normative stereoacuity values for Frisby Near and FD2, cross-checking earlier normative datasets.
Mehta, J., O'Connor, A.
2023
University of Liverpool, UK
Frisby had the narrowest limits of agreement (best test-retest reliability) of TNO, Frisby, Lang Stereopad and Asteroid.
Hahn, E., Comstock, D., Durling, S., MacCarron, J., Mulla, S., James, P., LaRoche, R.
2010
IWK Health Centre / Dalhousie University, Canada
The only stereotest of 7 major tests with zero monocular identification in either normal or strabismic subjects.
Anketell, P.M., Saunders, K.J., Little, J-A.
2013
Ulster University, UK
Normative dataset for 6-16 year-olds: median 20″ (primary) / 10″ (post-primary).
Westheimer, G.
2013
University of California, Berkeley, USA
The Frisby's design satisfies each of the criteria Westheimer (2013) set out for effective stereoacuity testing, as demonstrated by the evidence throughout this compendium.
C. Screening Performance in Amblyopia & Strabismus
Ohlsson, J., Villarreal, G., Abrahamsson, M., Cavazos, H., Sjöström, A., Sjöstrand, J.
2001
Gothenburg, Sweden / Monterrey, Mexico
Frisby recorded the highest individual sensitivity of the five stereotests tested, though — like all of them — it isn't sufficient alone for amblyopia/strabismus screening.
Nanda, K.D., Nischal, K.K.
2022
UPMC Children's Hospital of Pittsburgh, PA, USA
Frisby stereoacuity correlates with amblyopia severity, supporting its use for monitoring binocular status during treatment.
D. Stereopsis & Ageing
Wright, L.A., Wormald, R.P.W.
1992
Moorfields Eye Hospital, London, UK
In 728 patients over 65, only 27% had normal stereopsis on the Frisby test and prevalence of loss rose with age.
Garnham, L., Sloper, J.J.
2006
Moorfields Eye Hospital, London, UK
Frisby stereoacuity declined only mildly with age; unlike TNO, it did not show a sharp collapse to screening-level results in older subjects.
Schneck, M.E., Haegerstrom-Portnoy, G., Lott, L.A., Brabyn, J.A.
2000
Smith-Kettlewell Eye Research Institute, San Francisco, CA, USA
Age-related stereopsis loss on the Frisby test tracked ocular health, not cortical decline — healthy-eyed older adults showed no significant drop.
Gupta, P., Vu, T.A., Wong, C.M.J., et al.
2025
Singapore Eye Research Institute / Duke-NUS Medical School, Singapore
Frisby used as the depth-perception measure in a 2,380-participant population cohort study of vision and quality of life in older adults.
E. Major Multi-Centre Clinical Trials Using Frisby as an Outcome Measure
Infant Aphakia Treatment Study Group (Lambert, S.R., et al.)
2014/2015
Multi-centre, NIH-funded, USA
Frisby selected as one of three primary stereopsis outcome measures in a major NIH-funded multicentre RCT.
Infant Aphakia Treatment Study Group
2016
Multi-centre, NIH-funded, USA
Earlier surgery and better visual acuity were the strongest predictors of achieving measurable stereopsis.
Buck, D., et al.
2009
Multi-centre, UK
Stereoacuity did not predict which treatment a child received; control of the deviation did.
F. International Literature
Soto Pinzón, J.C., Urdiales Suárez, J.A. (advisor: Jurado Medina, S.P.)
2023
Universidad de La Salle, Bogotá, Colombia
Compared Frisby and Titmus against the Howard-Dolman in amblyopic children (undergraduate thesis).
Cirac, A., Jarabo, C., et al.
2016
Universidad de Zaragoza, Spain
Failure rates under 10% for all four tests, incl. Frisby, in 200 healthy young adults.
Hernández-Muñoz, M.T., Hernández-Ordóñez, T., De la Fuente-Torres, M.A.
2003
Mexico City / Ciudad Victoria, Mexico
100% specificity for strabismus and amblyopia in 1,048 Mexican children — a reliable rule-out screening tool.
Kawachi, E.
1983
Japan
One of the earliest non-English clinical evaluations of the Frisby, published within a decade of its 1975 launch.
Abe, H., et al.
2009
Japan
Peer-reviewed Japanese comparison, part of a sustained multi-year Japanese research programme on the Frisby.
Igarashi, T., et al.
2011
Japan
Real-world occupational screening of binocular vision in train drivers, a safety-critical profession.
G. Test-Selection & Usage Surveys
Vancleef, K., Read, J.C.A., et al.
2019
Newcastle University, UK / international
Frisby is the most-used stereotest in the British Isles for both younger and older children.
H. Screener Pocket Test: Clinical Use & Review
Optician CPD Series (n.d.)
n.d.
UK Author: Professor J. Frisby
Clinical CPD review of test procedure, scoring and screening use across the full Frisby range.
Hertzsprung, N., Krantchev, K., Picht, T., Roethe, A.L., Rubarth, K., Fuellhase, J., Vajkoczy, P., Acker, G.
2023
Germany
Frisby Pocket Stereotest used to screen participants' stereopsis before a neurosurgical informed-consent study — an independent, non-ophthalmic clinical use case.
Schlinkmann, N., Khakhar, R., Picht, T., Piper, S.K., Fekonja, L.S., Vajkoczy, P., Acker, G.
2022
Germany
Frisby Pocket Stereotest used to confirm normal stereopsis and balance study groups of neurosurgeons before a visualisation-memory task.
Part Two — Frisby Davis Distance Stereotest (FD2)
I. Distance Stereoacuity: Development, Validity & Clinical Application
Frisby, J.P., Patchick, E., Edgar, R., Davis, H.
2004
University of Sheffield, UK
FD2 stereoacuity did not correlate significantly with interpupillary distance, unlike general laboratory stereo-geometry tasks.
Adams, W.E., Hrisos, S., Richardson, S., Davis, H., Frisby, J.P., Clarke, M.P.
2005
Newcastle University, UK
All 59 children (aged 3–6 years) were successfully testable, establishing the first paediatric FD2 norms: mean stereoacuity of 29.6″ arc at 6m (76% of children) and 92.3″ arc at 3m (24%), with only 6.8% showing no measurable response.
Hong, S.W., Park, S.C.
2008
South Korea
Corroborates the Adams et al. (2005) paediatric FD2 norms in an independent population.
Eom, Y., Song, J.S., Ahn, S.E.
2013
South Korea
FD2 stereoacuity improved with increased IPD, matching real-world geometry, unlike a simulated 3D test.
Holmes, J.M., Fawcett, S.L.
2005
Mayo Clinic, Rochester, MN, USA
Developed a modified staircase presentation protocol that controls for monocular cues at larger disparities.
Adams, W.E., Leske, D.A., Hatt, S.R., Mohney, B.G., Birch, E.E., Weakley, D.R. Jr.
2008
Mayo Clinic, Rochester, MN, USA
FD2 documented measurable improvement in distance stereoacuity after surgery.
Saxena, R., Kakkar, A., Menon, V., Sharma, P., Phuljhele, S.
2011
India
Identifies clinical factors influencing FD2 distance stereoacuity measurement in intermittent exotropia.
Singh, A., Sharma, P., Singh, D., Saxena, R., Sharma, A., Menon, V.
2013
India
Proposed an FD2 distance-stereoacuity threshold (worse than 20″) to help time surgical intervention.
Bohr, I., Read, J.C.A., et al.
2013
Open-access, freely available full text
Fair agreement between near-Frisby and FD2 across the lifespan; documents childhood gains and late-adulthood decline.
Young, B.J., Sueke, H., Wylie, J.M., Kaye, S.B.
2009
St Paul's Eye Unit, Liverpool, UK
No subject achieved a passing score monocularly at 6 metres.
Eshaghi, M., Arabi, A., Banaie, S., Shahraki, T., Eshaghi, S., Esfandiari, H.
2021
Iran / USA
FD2 and near Frisby used as core outcome measures across 182 surgical patients.
J. The Mayo Clinic Stereoacuity Research Programme
Leske, D.A., Birch, E.E., Holmes, J.M.
2006
Mayo Clinic, Rochester, MN, USA
Patients consistently detected finer disparities on the real-depth Frisby/FD2 tests than on equivalent random-dot tests.
Holmes, J.M., Birch, E.E., Leske, D.A., Fu, V.L., Mohney, B.G.
2007
Mayo Clinic, Rochester, MN, USA
Helped establish the FD2's clinical role in evaluating intermittent exotropia, where distance stereopsis is a more sensitive indicator than near stereopsis.
Hatt, S.R., Mohney, B.G., Leske, D.A., Holmes, J.M.
2008
Mayo Clinic, Rochester, MN, USA
Stereoacuity in intermittent exotropia can genuinely fluctuate within a single day, regardless of which stereotest is used.
Adams, W.E., Leske, D.A., Hatt, S.R., Holmes, J.M.
2009
Mayo Clinic, Rochester, MN, USA
Established test-retest reliability thresholds for near-Frisby and FD2, giving clinicians a defensible bar for judging genuine treatment-related change.
Odell, N.V., Hatt, S.R., Leske, D.A., Adams, W.E., Holmes, J.M.
2009
Mayo Clinic, Rochester, MN, USA
Frisby and FD2 scores were less affected than random-dot tests under simulated monocular visual acuity loss.
K. Independent Expert Review
Read, J.C.A.
2015
Newcastle University, UK
Independent expert review situating Frisby/FD2 within the full clinical stereopsis and strabismus literature, corroborating and contextualising the Adams et al. (2009) reliability data.
This pack was compiled via a structured literature sweep of PubMed, publisher databases, institutional repositories and non-English-language sources subsequently translated into English. It is a comprehensive first-pass review, not an exhaustive systematic review — further studies may exist beyond what is catalogued here.
For distributors and academic partners: please contact us if you would like source PDFs of any individual study, or if you are aware of further Frisby Stereotest research — particularly non-English-language studies — that should be added to future editions of this compendium.
The studies summarised above are provided for informational purposes only and reflect published research that includes or discusses the Frisby Stereotests and related stereoacuity measurements. They do not constitute clinical guidelines or medical advice. Clinical use should follow local protocols and professional judgement.